Galera Therapeutics, Inc. (GRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0450
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
Galera Therapeutics Employees
Galera Therapeutics had 7 employees as of December 31, 2023. The number of employees decreased by 24 or -77.42% compared to the previous year.
Employees
7
Change (1Y)
-24
Growth (1Y)
-77.42%
Revenue / Employee
n/a
Profits / Employee
-$2,801,857
Market Cap
2.58M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7 | -24 | -77.42% |
Dec 31, 2022 | 31 | 1 | 3.33% |
Dec 31, 2021 | 30 | -8 | -21.05% |
Dec 31, 2020 | 38 | 6 | 18.75% |
Dec 31, 2019 | 32 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Galera Therapeutics News
- 22 days ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 5 months ago - Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 9 months ago - Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 9 months ago - Galera Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 10 months ago - Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Announces Receipt of Type A Meeting Minutes and Strategic Update - GlobeNewsWire
- 1 year ago - Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem - GlobeNewsWire